{
      "brief_title": [
            "insulin",
            "neurogenetics",
            "memory",
            "alzheimer",
            "disease"
      ],
      "brief_summary": [
            "study",
            "examine",
            "use",
            "compound",
            "therapeutic",
            "agent",
            "cognitive",
            "impairment",
            "alzheimer",
            "disease"
      ],
      "condition": [
            "disease"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "rosiglitazone"
      ],
      "criteria": [
            "men",
            "woman",
            "mild",
            "alzheimer",
            "disease",
            "without",
            "serious",
            "medical",
            "psychiatric",
            "comorbid",
            "condition"
      ],
      "gender": "All",
      "minimum_age": [
            "55",
            "year"
      ],
      "maximum_age": [
            "80",
            "year"
      ],
      "healthy_volunteers": "No",
      "mesh_term": [
            "disease"
      ],
      "id": "NCT00018382"
}